What it takes to get reimbursed in women’s health - the Hello Inside story
The 18-month company rebuild behind Hello Inside’s deal with Germany's statutory insurer BARMER
Getting a women’s health product reimbursed through a public healthcare system can take years - if at all.
And earlier this year, Austrian women’s metabolic health company Hello Inside achieved just that, securing a deal with German statutory insurer BARMER, giving members access to its prevention programme.
For context, Hello Inside uses continuous glucose monitoring, behavioural data and AI-supported recommendations to help users understand links between metabolism, symptoms, nutrition, stress and hormonal health.
And BARMER is one of Germany’s largest statutory health insurers, covering more than nine million people. Securing reimbursement through a statutory insurer gives startups something difficult to achieve through direct-to-consumer models alone: integration into the healthcare system itself, alongside large-scale distribution and institutional credibility. It’s a big deal.
In this interview with FutureFemHealth, Hello Inside’s CEO Mario Aichlseder explains how the company spent 18 months transforming itself from a consumer health startup into a reimbursement-ready healthcare company, what it took to secure reimbursement with one of Germany’s largest insurers, and the lessons other women’s health founders can take from the journey.
